La médecine personnalisée est prometteuse pour les cancers récurrents et les superbactéries, mais elle demande beaucoup de travail et d’argent. Les approbations réglementaires demeurent compliquées.
- Professor of Biocchemistry and Biomedical Sciences, McMaster University
Personalized medicine is a promising treatment for recurrent cancer and superbugs, but it is labour-intensive and expensive, and pathways for its regulatory approval and reimbursement are complicated.
We asked 7 global experts in microbiology and biochemistry if we are headed towards a future with no antimicrobial agents.
We asked 7 global experts in microbiology and biochemistry if we are headed towards a future with no antimicrobial agents.
Canada lags behind other developed countries in access to newer antimicrobials. Here’s why that matters, and what can be done about it.
Antimicrobial resistance is a public health and economic disaster waiting to happen. If we do not address this threat, by 2050 more people will die from drug-resistant infections than from cancer.
Contact Lori for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Hamilton, ON
- Website
- X (formerly Twitter): @Dr_Lori_Burrows
- Article Feed
- ORCID
- Joined
